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Presented here is the design of the Mechanical Ventilator Milano (MVM), a novel mechan-
ical ventilator designed for rapid mass production in response to the COVID-19 pandemic
to address the urgent shortage of ventilators in many countries, and the growing difficulty in
procuring these devices through normal supply chains across borders. This ventilator is an
electro-mechanical equivalent of the old, reliable Manley Ventilator, able to operate in both
independent and patient-assisted modes. The design is optimized to permit large-sale pro-
duction in a short amount of time and at a limited cost, relying on off-the-shelf components,
readily available worldwide. Operation of the MVM requires only a source of compressed
oxygen (or compressed medical air) and electrical power. The MVM control and monitoring
unit can be connected and networked via WiFi so that no additional electrical connections
are necessary other than the connection to the electrical power. Initial tests of a prototype
device with a silicon test bag lung are also presented. Further tests and developments are
underway. At this stage the MVM is not yet a certified medical device but certification work
is in progress.
1. INTRODUCTION
The large number of people affected by SARS-CoV-2 has created an urgent demand for ventila-
tors on a global basis, a demand that exceeds the capacity of the existing supply chains, especially
in some regions where cross-border supply has been disrupted. This need has motivated the devel-
opment of the mechanical ventilator (Mechanical Ventilator Milano, MVM) - a reliable, fail-safe,
and easy to operate mechanical ventilator that can be produced quickly, at large scale, based on
readily-available parts. It was inspired by the Manley ventilator [1], which was proposed in 1961,
based on “the possibility of using the pressure of the gases from the anaesthetic machine as the mo-
tive power for a simple apparatus to ventilate the lungs of the patients in the operating theatre” [2].
The MVM is designed with the same principle of simplicity in mind. The MVM does not include
a system to measure the tidal volume provided to the patient directly with each breathing cycle,
but rather, uses a system to measure the peak and average expiratory flow rate. The MVM is
compliant with the guidelines for “Rapidly Manufactured Ventilator System (RMVS)” [3], recently
released by the UK Medicine & Healthcare products Regulatory Agency.
The current version of this paper includes revisions that have been made to date from our testing
and from recommendations from the medical experts with whom we are working. This version of
the paper contains as much of that detail as possible to make available our progress to date.
However, there may be further changes as we proceed with our testing process and as we look for
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the availability of specific parts that may vary from country to country. We are also proceeding with
the required tests for certification of this ventilator, working with regulators in Italy and several
other countries
The MVM uses a pressure controlled ventilation (PCV) mechanism, and can be operated in both
independent and patient-assisted control modes.
The system connects directly to a line of pressurized medical oxygen or medical air, and relies on
regulation of the flow to deliver medical air, medical oxygen, or a mixture of air and oxygen to the
patient at a pressure in the range 20–80 mbar/cm H2O. Pressure regulation of the end-expiratory
cycle is achieved by discharging the expiratory flow through a valve which sets the desired minimum
positive end-expiratory pressure (PEEP) at 5 mbar/cm H2O. Another adjustable pressure limiting
valve is connected to the delivery line and ensures that the maximum pressure delivered does not
exceed the pre-set value.
Important features of the MVM are:
Small Number of Components: the MVM consists of a medical care flowmeter [4] for di-
rect regulation of the maximum flow rate, an oxygen-therapy humidifier [4], three electrically-
controlled, VDC-actuated proportional valves (two in parallel), a pressure sensor, four manual
valves, medical tubing, and the control system directly connected to the proportional valves and
to the control sensor; backup power for the control system is provided by a VDC battery;
Ease of Procurement: the parts required for the construction of the MVM have been selected
based on those that are available in many nations globally. The parts selected are also charac-
terized by their ease of use in large-scale manufacturing and assembly;
Simplicity of Construction: assembly of the parts into a complete MVM is achievable based
on a small set of clear instructions. The process for loading the software into the controller is
simple. The controller software is open source and available for customization by end users;
Cost Containment: the total cost of the components is in the hundred e ’s.
Convenience of Deployment: the device requires only connection to a line of pressurized oxygen
and standard AC electrical power (either 220 V or 110 V); this makes it suitable for home care,
use in ambulances, and readily deployable in medical clinics with centralized oxygen and air
supply systems, such as COVID-19 hospitals or COVID-19-care areas in general hospitals;
Customizability: the MVM can operate in different ventilation modes (independent and patient-
assisted) as described in Section 3. Also, the operating parameters can be tuned by the operator
with a simple user interface;
Scalability: the MVM control system is based on a WiFi micro-controller that allows both for
local control of the system and for monitoring and tuning of the parameters of multiple units
from a single work station.
Reliability: the components in the MVM are commercial and readily available. We note that the
reliability of MVM has to be carefully studied based on the specifications of the components.
The system is designed to be easy to repair, just by replacing any non-functioning parts.
Limited oxygen consumption: the consumption of oxygen with this device will not exceed
6 LPM
2. DESIGN AND COMPONENTS
The conceptual design and P&ID of the MVM are shown in Fig.1. The main components are
described following the order of the oxygen flow:
Connection to oxygen and air supply: at the left-hand side, the MVM is connected to a pres-
surized oxygen/air line.
Medical care flowmeter MCF1: The air flow is controlled a medical care flowmeter MCF1,
which restricts the flow to a maximum value.
Medical care flowmeter MCF2: The oxygen flow is controlled by medical care flowmeter
MCF2.
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FIG. 1. Conceptual design and P&ID of MVM. Note: 1 mbar corresponds to the pressure of a H2O columns
of 1 cm height.
Sintered filters: the sintered filters SF1/SF2 remove particulate in the inline that can clog the
pipes.
Venturi mixer: The oxygen and air flow are mixed in a medical venturi mixer device.
Air/Oxygen delivery proportional valve PV1: The incoming gas flow is controlled by the
proportional PV1 with an industrial process control algorithm that ensures a proper respiratory
minute volume is delivered to the patient;
Adjustable Pressure limit APL valve PV3: Mechanical valve that sets the value of the max-
imum inspiratory pressure in the range 20–30 mbar
Negative Pressure Relief valve PV4: a check valve to avoid any negative pressures when the
patient is in active mode and demands more air. As long as there is a positive pressure in the
respiratory lines this valve will remain closed. A bacterial/viral filter upstream may be required.
O2 sensor S1: The optional O2 sensor O2S1 is used to measure continuously the fraction of in-
spired oxygen FiO2.
Spirometer SP1: an optional digital spirometer is connected to the input line to monitor the
peak and average inspiratory flow rates.
Breathing system: the breathing system, connected to the tracheal tube, supports the attach-
ment of two plastic tubes of typical size 22 mm connecting respectively to pneumatic valves PV1
and PV2L(H), and to a smaller plastic tube leading to two differential pressure sensors PS1 and
PS2 to monitor pressure and flow. The standard for connection of the breathing system is the
22 mm cone and socket combination defined in the standard [5].
Condensate trap CT1: the expiration tube passes through a condensate trap allowing for re-
moval of condensed vapor from the patient’s breath.
Silicone Membrane SM: the silicone membrane SM obstructs access to the machine of the wet
flow.
Expiration valve PV2: high throughput PV2L(H) valves control the expiratory flow. An ade-
quate orifice diameter guarantees the flow corresponding to the expiration of a proper respiratory
minute volume at the given PEEP value.
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Spirometer SP2/O2S1: an optional, second, digital spirometer and oxygen sensor are connected
to the output circuit to measure the expiratory flow rates and oxygen intake.
PEEP Valve PV5: a set of mechanical valves that control the positive end-expiratory pressure
in the range 5-20 mbar. A pair of Mechanical valves PV5L, PV5H control the PEEP in a higher
(H) or lower range (L).
Bacterial/Viral-Retentive Filter F1: This disposable filter can be set on the line connected
with the patient.
A CAD design of the MVM controller base assembly box of Fig.1 is shown in Fig. 2.
FIG. 2. The MVM controller base assembly with ports to connect.
3. CONTROL SYSTEM AND OPERATION
The control system performs supervision and actuation of the two valves (PV1 and PV2) based
on the programmed respiratory cycle.
The pressure sensor, PS1, detects the pressure at the mask of the patient, which is then used by
the control system to verify the pressure and then appropriately adjust the two valves to ensure
that the pressure is always within the operating range: 20–30 mbar for the inspiratory phase and
5 mbar for the expiratory phase.
During the inspiratory phase, PV2 is closed and PV1 is open. When the pressure measured by PS1
reaches a constant value within the design range, at the end of the inspiratory cycle, PV1 is closed
and PV2 is opened after a small pause. This allows the discharge of the lung pressure. The ending
expiratory pressure is set by PEEP PV5.
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The main controller runs on a (Arduino-compatible) micro-controller board based on a 32 bit
micro-controller with WiFi/Bluetooth connectivity. All boards of this type have a small form factor
and integrate all I/O functions required for this project.
A daughter board interfaces to the controller and provides four opto-coupled switches to operate
the electrically-controlled pneumatic valves. The daughter board is provided with 24 V VDC supply
and includes the low voltage regulator to supply the central unit.
The differential pressure gauges are based on a 60 mbar differential pressure sensor with a reso-
lution better than 0.2 mbar.
The WiFi connectivity of the board offers the option for central monitoring and configuration.
A buzzer and a high luminosity LED are available to signal alarms.
The MVM is equipped with an industrial power supply unit capable of at least 50 W and battery
backup operated in fail-safe mode. Under normal circumstances, the power supply will feed the
controller and keep the battery charged. In case of power failure, the battery will automatically
provide the power for ongoing system operation for up to 30 min. The power supply is hosted in a
separate enclosure to provide isolation between the oxygen lines and possible spark sources. The
power supply unit will include two 12 V, 1.2 A h batteries.
3.1. Continuous Mandatory Ventilation mode
In the CMV configuration, the unit will operate the valves in regular cycles, defined by the
operator through the inspiratory time, PEEP, and respiratory rate. The operator is also required
to define the maximum inspiratory pressure threshold, which cannot be exceeded by the system
for patient safety. Alarms are set on the basis of the inspiratory pressure, the minute ventilation,
and the tidal volume, measured by the system itself. Preliminary ranges of values for control and
alarm parameters are listed in table I.
TABLE I. Preliminary ranges of values for control and alarm parameters for MV mode operation of MVM.
Control parameter Range Step
Respiratory rate 4–50 rpm 1 rpm
Inspiratory time 0.4–1.5 s 0.1 s
PEEP 5–20 mbar mechanical
Max inspiratory pressure 20–80 mbar mechanical
FiO2 21–100 % mechanical
Alarm parameter Range Step
Inspiratory pressure 10–80 mbar 1 mbar
Tidal volume 50–1500 mL 50 mL
Minute ventilation 2–20 slpm 1 slpm
3.2. Assisted Ventilation Mode
In AV mode, the patient triggers the ventilator. Inspiration pressure support is given at a preset
constant pressure. The ventilator regulates the pressure during inspiration so that it corresponds
to preset values within the operating ranges listed in table II.
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TABLE II. Preliminary ranges of values for control and alarm parameters for AV mode operation of MVM.
Control parameter Range Step
PEEP 5–20 mbar mechanical
Max inspiratory pressure 20–80 mbar mechanical
FiO2 21–100 % mechanical
Fraction of inspiratory flow 5–20 % 1 %
Alarm parameter Range Step
Inspiratory pressure 10–80 mbar 1 mbar
Tidal volume 50–1500 mL 50 mL
Minute ventilation 2–20 slpm 1 slpm
4. TESTS WITH A SILICON TEST BAG LUNG.
A series of tests with a silicon test bag lung has been performed in which the simulator lung was
set to a number of different values of compliance and resistance. The pressure at the lung and the
flow-rate as measured by PS1 and the SP1, respectively, were recorded.
An example of these data is shown in
Fig.3 shows the waveforms averaged over 10 cycles, for a simulated lung compliance (dV/dP ) of
15 ml/mbar. The other parameters are displayed in the figures themselves.
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FIG. 3. Waveforms averaged over 10 cycles for a simulated lung compliance of 15 ml/mbar: the flow (black
line), as measured by the spirometer SP1, and the pressure at the lung (red line) as measured by pressure
sensor PS1.
Fig.4 shows the waveforms averaged over 10 cycles, for a simulated lung compliance (dV/dP ) of
20 ml/mbar. The other parameters are displayed in the figures themselves.
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FIG. 4. Waveforms averaged over 10 cycles for a simulated lung compliance of 20 ml/mbar: the flow (black
line), as measured by the spirometer SP1, and the pressure at the lung (red line) as measured by pressure
sensor PS1.
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Appendix A: MVM Control Unit
The MVM control system includes electronics that control the solenoid valves, and the sensors.
Its configuration can be controlled locally with an LCD touch screen as well as remotely via wi-fi
connection. A schematic description is given below:
1. Each MVM unit includes three electronic boards: a micro-controller; an interface board based
on Raspberry Pi 4TM with an LCD display; and the connection hub. The first two are readily
available commercial components. The connection hub is a custom design by LNGS and is
produced by Elemaster. The connection hub, shown in Fig. 5, includes the pressure sensor,
the opto-controller for the solenoid of the valves, and the I2C ports for the gas flow meter.
FIG. 5. The Gerber of the MVM connection hub for the MVM control system (preliminary version).
A prelimnary design of the GUI is shown in Fig.6.
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FIG. 6. GUI (top) and example setting of parameters (bottom) (preliminary version).
2. MVM units are designed to operate both in local and in remote modes, with the remote mode
allowing for centralized control and monitoring. Moreover, it will be possible to update the
firmware of the units and diagnose defective devices remotely over a network. To operate in
remote mode:
• A proper network infrastructure has to be deployed. The network should include several
high reliability access points and routers with proper security measures for network
integrity and data protection.
• Network infrastructure must include one redundant installation of an MQTT server
with database logging and workstations to allow operators to monitor the MVM units.
• Remote configuration and monitoring of the MVM units is realized via the MQTT
protocol with a proper user interface required for operators to centrally monitor the
parameters and modify the configuration. The user interface runs in centralized mode
on personal computer workstations. A second user interface can be implemented for
mobile phones (using an already available MQTT applet configured properly). The
applications have different levels of authorization and authentication. A scheme of the
scalable proposed network of MVM devices is shown in Fig. 7. The network hardware
connection is shown in Fig. ??
9
FIG. 7. The structure overview with the connection of the single components of the MVM network for
remote control and monitoring of patients by the hospital staff.
• The critical operations of the valves and sensors are manged by the core firmware
running on the micro controller.
• The local interface with the user is through a touchscreen LCD, which also displays
operating parameters.
• The local Raspberry processor will also run the MQTT client to dispatch commands
received from remote users.
• A validation procedure is foreseen to test the electrical and firmware functionality of
the units once produced.
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